Physician profile
Paul Atlas
NPI 1093776882
$5,852.14
in general payments reported to CMS, 2019-2025
33 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what 86% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $786 · 2021: $561 · 2022: $531 · 2023: $1,192 · 2024: $778 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,979.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,446.06 | 2019-2025 | Affinity, Affinity, Puraply |
| Smith+Nephew, INC. | $1,279.76 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Renasys Touch |
| Treace Medical Concepts, INC. | $384.24 | 2025 | |
| Bioventus LLC | $334.56 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Advanced Oxygen Therapy INC. | $296.36 | 2021-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Stryker Corporation | $273.89 | 2020-2025 | Citrefix, Easyfuse, Variax |
| Reprise Biomedical, INC. | $229.26 | 2024-2025 | Miro3d |
| Kci USA, INC. | $227.45 | 2019-2023 | V.A.C. Veraflo, V.A.C. Dermatac |
| Misonix INC | $187.95 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $137.52 | 2021-2024 | Nuzyra |
| Osiris Therapeutics INC. | $134.34 | 2019 | |
| Fidia Pharma USA INC. | $127.75 | 2020-2022 | |
| Medtronic, INC. | $98.07 | 2023 | Intellis Adaptivestim |
| Lifenet Health | $92.59 | 2023 | |
| Tactile Systems Technology INC | $65.92 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $59.59 | 2019 | |
| Mimedx Group, INC. | $55.38 | 2024-2025 | |
| Paragon 28, INC. | $45.15 | 2019-2023 | Portfolio |
| Merck Sharp & Dohme LLC | $41.37 | 2019 | |
| Urgo Medical North America, LLC | $40.55 | 2025 | Urgoclean Ag |
| Orthofix Medical, INC. | $39.63 | 2024 | Physio-Stim |
| Horizon Therapeutics Plc | $34.76 | 2019-2021 | |
| Melinta Therapeutics, LLC | $29.80 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.76 | 2022 | |
| Depuy Synthes Sales INC. | $25.73 | 2024 | Motoband, Dynaforce |
| Ani Pharmaceuticals, INC. | $20.24 | 2025 | Purified Cortrophin Gel |
| Kerecis Limited | $20.10 | 2021 | |
| Seapearl East, INC | $18.82 | 2023 | |
| Alfasigma USA, INC. | $17.50 | 2021 | |
| Hydrofera LLC | $16.70 | 2022 | |
| Integra Lifesciences Corporation | $15.42 | 2020 | |
| Cardiovascular Systems INC. | $15.03 | 2019 | |
| Arthrosurface Incorporated | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Atlas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.